Tabradol
- Manufacturer
- California Pharmaceuticals, LLC
- Effective date
- 2016-01-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:21:47
Label at a glance#
ProductTabradol
Active ingredientCYCLOBENZAPRINE HYDROCHLORIDE
Label structure5 sections
Label contents#
Full prescribing information#
Tabradol - Label
Tabradol - Inactive ingredient - flavor label
Tabradol - Pharmacist instructions Page 1
Tabradol - Principal Label
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CYCLOBENZAPRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Code 128 | 70332-106-01 | Tabradol Principal Display CS125-A1 - Label Tabradol Kit - California Pharma LLC.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 51048710-225c-aa41-d0e7-eed095d02838 | Product name | 4 | 20250331 |
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| c2c26dc9-7e16-fc02-7eba-6b46ed3515ee | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70332-106-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fb42-f424-e053-dadaa90a57ce | Tabradol |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70332-106-01 | Tabradol | 1 in 1 KIT | KIT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70332-106-01 | ML - Milliliter | 70332-106 | 1ea1b8f8-21a4-4e11-8833-7ea55454278c | 1 | 2016-09-02 |
Products#
Every source-derived product name is available through these pages.
- Tabradol
- Cyclobenzaprine Hydrochloride
- Structured Suspension Vehicle
- Suspension
- SORBITOL
- WATER
- GLYCERIN
- CITRIC ACID MONOHYDRATE
- POTASSIUM SORBATE
- SODIUM BENZOATE
- DIMETHYL SULFONE
- SACCHARIN SODIUM
- CYCLOBENZAPRINE
- Structured Flavoring Vehicle
- Flavor
- CHERRY
- SODIUM CITRATE
- XANTHAN GUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70332-106 | 70332-106-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SORBITOL | 506T60A25R | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| DIMETHYL SULFONE | 9H4PO4Z4FT | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| CYCLOBENZAPRINE HYDROCHLORIDE | 0VE05JYS2P | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| CHERRY | BUC5I9595W | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| WATER | 059QF0KO0R | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 273003a5-23aa-21e4-e054-00144ff88e88 | 273003a5-23a9-21e4-e054-00144ff88e88 | 2016-01-01 | 273003a5-23aa-21e4-e054-00144ff88e88 273003a5-23a9-21e4-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




